Definitive Contract HHSN266200400054C
- Not listed
- This is a $961,258 Definitive Contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Yeshiva University, a private non-profit educational institution. The contract is for BIOMEDICAL (BASIC) services and has an ultimate completion date of January 14, 2011. The contract is not set aside for any special categories of businesses. The contract supports the major program "TOWARDS MAXIMIXING THE SCIENTIFIC...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private academic medical center and research institution located in New York, NY. The $18,691,713.00 cost-no-fee definitive contract is for biomedical research services, with a period of performance ending on March 31, 2011. The contract does not have a set-aside designation....
- This federal contract award is to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution in New York City. The contract, valued at $399,266.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to support the development of animal models of infectious diseases. The award is a delivery order under NIAID's larger "Animal Models of Infectious Diseases...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $42,132,619.00 definitive contract to the Icahn School of Medicine at Mount Sinai (ISMMS) for the NIAID Centers of Excellence for Influenza Research and Surveillance program. This cost-no-fee contract, awarded on March 30, 2007, has a performance period ending on May 23, 2017. ISMMS, a private university and non-profit organization, will...
- This federal contract award to the Icahn School of Medicine at Mount Sinai (ISMMS) was made by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct research on "Modeling Immunity for Biodefense". The $17,219,467.21 cost-no-fee contract has a period of performance from September 30, 2010 to September 29, 2015 and does not have a set-aside designation. Under this award, ISMMS is collaborating with several subcontractors, including the California Institute of...
- This federal contract award is for the "MODELING IMMUNITY FOR BIODEFENSE" program, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS), a private non-profit educational institution. The award is a $23,517,489.00 definitive contract with a cost-no-fee pricing type, with a period of performance from September 29, 2005 to September 29, 2010. The contract does not have a set-aside designation. ISMMS, a renowned...
- This is a $10,000 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Bar Ilan University, a leading public research university in Israel. The contract is for pharmacokinetic analysis of patient samples, with an ultimate completion date of April 29, 2010. Bar Ilan University has received multiple federal awards, including prime and sub-awards from agencies such as the Department of State, NIH, Department of Defense, and...
- This is a $6,223,512.88 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, for "Targeted Clinical Research to Address Select Viral Infections". The contract has no set-aside designation. The prime contractor is Northwestern University, a private research university, which will be supported by multiple academic subcontractors including Georgetown University, Vanderbilt University...
- This federal contract award, valued at $121,633.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS) for the development of mouse models to support research on low pathogenic seasonal and pandemic influenza viruses. The period of performance is from September 9, 2013, through September 8, 2014, with a final completion date of May 8, 2015. This award is a delivery order under the NIAID Animal Models of...
- This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $10,236,804.91, is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract does not have a set-aside designation. The contract is described as "TAS::75 0885::TAS", which likely refers to the task or service area, though the specific details are not provided. The...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID) to Yeshiva University, a private university and non-profit organization located in New York, NY. The contract, valued at $10,921,277.29, is for identifying targets for therapeutic interventions using proteomics technology. The contract is a definitive contract with a cost-no-fee pricing type and has a completion date of November 22, 2013. This contract is not set aside for any special designation. Yeshiva University has also received other federal contract awards and grants from agencies such as the National Science Foundation, Department of Agriculture, Department of Defense, and National Institutes of Health for research in various fields including mathematics, physics, engineering, medical sciences, and diabetes translation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 11 | Other Administrative Action | $0 | 11/22/13 | |
| 12 | Other Administrative Action | ($1) | 11/22/13 | |
| 10 | Funding Only Action | $145.9k | 6/3/09 | |
| 9 | Other Administrative Action | $0 | 8/27/08 | |
| 8 | Funding Only Action | $1.0m | 6/24/08 |